Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

被引：23

作者：

Cortes-Borra, Albert ^{[1
]}

Aranda-Abreu, Gonzalo Emiliano ^{[2
]}

机构：

[1] Vall dHebron Barcelona Hosp Campus, Barcelona, Spain

[2] Univ Veracruzana, Inst Invest Cerebrales, Xalapa, Veracruz, Mexico

来源：

PHARMACOLOGICAL REPORTS | 2021年 / 73卷 / 03期

关键词：

Amantadine; SARS-CoV-2; Prevention; COVID-19;

D O I：

10.1007/s43440-021-00231-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. Methods We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson's disease. Results Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus. Conclusion Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.

引用

页码：962 / 965

页数：4

共 19 条

[1] Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D [J].

Abbink, Peter ;

Lemckert, Angelique A. C. ;

Ewald, Bonnie A. ;

Lynch, Diana M. ;

Denholtz, Matthew ;

Smits, Shirley ;

Holterman, Lennart ;

Damen, Irma ;

Vogels, Ronald ;

Thorner, Anna R. ;

O'Brien, Kara L. ;

Carville, Angela ;

Mansfield, Keith G. ;

Goudsmit, Jaap ;

Havenga, Menzo J. E. ;

Barouch, Dan H. .

JOURNAL OF VIROLOGY, 2007, 81 (09) :4654-4663

[2] Amantadine as a drug to mitigate the effects of COVID-19 [J].

Aranda Abreu, Gonzalo Emiliano ;

Hernandez Aguilar, Maria Elena ;

Herrera Covarrubias, Deissy ;

Rojas Duran, Fausto .

MEDICAL HYPOTHESES, 2020, 140

[3] Observational study of people infected with SARS-Cov-2, treated with amantadine [J].

Aranda-Abreu, Gonzalo Emiliano ;

Aranda-Martinez, Jose D. ;

Araujo, Ramiro ;

Hernandez-Aguilar, Maria Elena ;

Herrera-Covarrubias, Deissy ;

Rojas-Duran, Fausto .

PHARMACOLOGICAL REPORTS, 2020, 72 (06) :1538-1541

[4] Use of amantadine in a patient with SARS-CoV-2 [J].

Aranda-Abreu, Gonzalo Emiliano ;

Aranda-Martinez, Jose Dolores ;

Araujo, Ramiro .

JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) :110-111

[5] Amantadine Treatment for People with COVID-19 [J].

Araujo, Ramiro ;

Dolores Aranda-Martinez, Jose ;

Emiliano Aranda-Abreu, Gonzalo .

ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (07) :739-740

[6] Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2 [J].

Baig, Abdul Mannan ;

Khaleeq, Areeba ;

Syeda, Hira .

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (06) :1430-1433

[7] Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes [J].

Choi, Seong Woo ;

Shin, Jin Soo ;

Park, Soon-Jung ;

Jung, Eunhye ;

Park, Yun-Gwi ;

Lee, Jiho ;

Kim, Sung Joon ;

Park, Hun-Jun ;

Lee, Jung-Hoon ;

Park, Sung-Min ;

Moon, Sung-Hwan ;

Ban, Kiwon ;

Go, Yun Young .

ANTIVIRAL RESEARCH, 2020, 184

[8] Potentially repurposing adamantanes for COVID-19 [J].

Cimolai, Nevio .

JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) :531-532

[9] Does amantadine have a protective effect against COVID-19? [J].

Cortes Borra, Albert .

NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (03) :284-285

[10] Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases [J].

Dembitsky, Valery M. ;

Gloriozova, Tatyana A. ;

Poroikov, Vladimir V. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 529 (04) :1225-1241

← 1 2 →